A Phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-? in patients with metastatic renal cell carcinoma-Reference-Cited by-同舟云学术

A Phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-? in patients with metastatic renal cell carcinoma

Published:2002-05-14 Issue:10 Volume:94 Page:2602-2609
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ryan Christopher W.,Vogelzang Nicholas J.,Stadler Walter M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference26 articles.

1. Treatment of 283 Consecutive Patients With Metastatic Melanoma or Renal Cell Cancer Using High-Dose Bolus Interleukin 2

2. Subcutaneous interleukin-2 plus interferon alfa-2a in metastatic renal cancer: an outpatient multicenter trial.

3. Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma

4. Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Visualization of epithelial cell adhesion molecule‑expressing renal cell carcinoma xenografts using designed ankyrin repeat protein Ec1 labelled with ^99mTc and ¹²⁵I;Oncology Letters;2022-11-17

2. Generalization of information substantiating the method of subcutaneous administration of recombinant human interleukin-2;Terapevt (General Physician);2021-10-16

3. Cytotoxic chemotherapy in the treatment of advanced renal cell carcinoma in the era of targeted therapy;Critical Reviews in Oncology/Hematology;2015-12

4. A Phase I Trial of Sorafenib Plus Gemcitabine and Capecitabine for Patients With Advanced Renal Cell Carcinoma;American Journal of Clinical Oncology;2011-10

5. Review: Targeted therapy in renal cancer;Therapeutic Advances in Medical Oncology;2009-11